Immix Biopharma, Inc.
IMMX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22 | -$16 | -$8 | -$24 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $1 | $0 |
| Change in WC | $4 | $2 | $0 | -$0 |
| Other Non-Cash | $3 | $0 | $0 | $23 |
| Operating Cash Flow | -$15 | -$11 | -$7 | -$2 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$0 | $0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$0 | $0 |
| Stock Issued | $16 | $16 | $3 | $19 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | -$0 | $0 |
| Financing Cash Flow | $16 | $15 | $3 | $19 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | $0 | $4 | -$4 | $17 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18 | $13 | $18 | $0 |
| End Cash | $18 | $18 | $13 | $18 |
| Free Cash Flow | -$16 | -$11 | -$7 | -$2 |